|
Raj Prabhakar, M.B.A. joined Celsion in January 2004 and served as Director of Program Management leading the liver cancer program from preclinical stage through launch of the global Phase III HCC study. He was promoted to his current position of Senior Director of Strategic Planning and Business Development in December 2007. Raj has nearly seven years of biomedical industry experience including Celsion, Protiveris (proteomics), Osiris Therapeutics (stem cells) and Harvard Medical School (orthopedic implants). Prior to receiving his M.B.A., Raj held analyst and associate positions for four years in several finance, venture capital and private equity firms. In addition to 11 years of experience, Raj holds an M.B.A. from the Harvard Business School and dual B.S. degrees from MIT in biology and mechanical engineering. | 